Silence Therapeutics (SLN) Retained Earnings (2018 - 2025)
Silence Therapeutics' Retained Earnings history spans 8 years, with the latest figure at -$3.0 million for Q4 2025.
- On a quarterly basis, Retained Earnings rose 99.37% to -$3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.0 million, a 99.37% increase, with the full-year FY2025 number at -$3.0 million, up 99.37% from a year prior.
- Retained Earnings hit -$3.0 million in Q4 2025 for Silence Therapeutics, up from -$550.8 million in the prior quarter.
- Over the last five years, Retained Earnings for SLN hit a ceiling of -$3.0 million in Q4 2025 and a floor of -$550.8 million in Q3 2025.
- Historically, Retained Earnings has averaged -$359.5 million across 5 years, with a median of -$353.8 million in 2023.
- Biggest five-year swings in Retained Earnings: crashed 40.74% in 2021 and later soared 99.37% in 2025.
- Tracing SLN's Retained Earnings over 5 years: stood at -$300.6 million in 2021, then fell by 2.74% to -$308.8 million in 2022, then decreased by 22.44% to -$378.1 million in 2023, then decreased by 25.39% to -$474.0 million in 2024, then soared by 99.37% to -$3.0 million in 2025.
- Business Quant data shows Retained Earnings for SLN at -$3.0 million in Q4 2025, -$550.8 million in Q3 2025, and -$529.8 million in Q2 2025.